Buyer	NHS England — not a council we hold
Supplier	Deloitte LLP

The ISFE2 programme is a GMPP and replaces a key piece of national infrastructure. After a red IPA review in February, NHSE brought in expertise and support to get the programme back on track, and the following IPA review in May was Amber. The IPA were clear that the additional support was essential and should be continued; this business case extends the support for 12 months at a maximum cost of £4.75m. Wherever possible NHS England will use alternative resource to reduce the cost, but if we were not able to do that then £4.75m would be the maximum value.

Runs	15 Jul 2024 to 27 Jun 2025
OCID	ocds-b5fd17-707838da-aeab-42b5-be52-5e3ae4553447
Notice	Read it on Contracts Finder

Figures are as published An award value in OCDS may be a framework ceiling rather than a sum anyone expects to spend, so a large figure here is not evidence of a large purchase.